Tremor Control and Patient Reported Outcomes after Bilateral Focused Ultrasound Thalamotomy for Essential Tremor
Movement Disorders Clinical Practice · 2026-07 · 13 (7) · 1653-1661
DOI: 10.1002/mdc3.70412 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders Clinical Practice, online erschienen am 29.10.2025. Verfasst von Nathan J Pertsch und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Rush University Medical Center, Chicago, IL, USA. Hauptthemen laut MEDLINE: Essential Tremor, Thalamus, Patient Reported Outcome Measures. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Staged bilateral magnetic resonance‐guided focused ultrasound (MRgFUS) thalamotomy is FDA approved to treat essential tremor (ET), but patient‐reported outcomes and satisfaction data are limited.
Objectives
We present tremor outcomes, patient‐reported adverse effects, and satisfaction in a cohort of 30 treated patients.
Methods
Patients underwent staged bilateral MRgFUS thalamotomy from 2020 to 2024, with minimum three‐months of follow‐up. Upper extremity tremor was assessed using the Clinical Rating Scale for Tremor Part B. Patients were asked directly about speech changes, sensory changes, gait disturbance, dysphagia, taste changes, ataxia, weakness, and satisfaction with bilateral treatment.
Results
Thirty patients underwent staged bilateral MRgFUS, of which 25 (83%) have 6 months, 20 (67%) have 12 months, and 10 (33%) have 24+ months of follow‐up. Tremor severity at baseline was similar bilaterally and was significantly improved bilaterally by treatment ( P < 0.001); however, not as greatly on the second treated side. Twenty‐six patients (87%) reported at least one new mild or moderate adverse effect after bilateral treatment; no severe adverse effects were reported. Notably, at 12 months 55% reported persistent speech changes, 30% reported persistent sensory changes, and 20% reported persistent gait disturbance. At 3 and 6 months of follow‐up, more than 80% of patients reported that they would repeat second‐side treatment in retrospect, but this declined to 67% at 12 months, and 60% at 24+ months.
Conclusion
Significant bilateral tremor control was achieved after bilateral MRgFUS thalamotomy for ET, but rates of some adverse effects were higher than previously reported.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Rush University Medical Center, Chicago, IL, USA.
- Rush University Parkinson's Disease and Movement Disorders Program, Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA.
ORCID-Profile: Nathan J Pertsch, Kazuki Sakakura, Havish Gattu
Zitieren
APA
Pertsch, N. J., Sakakura, K., Mueller, J. M., Kim, D., Ahn, Y. J., Chiu, L. T., Varela, J. R., Gattu, H., Patel, S., Pearce, J. J., Swan, C. B., Patel, N., & Sani, S. (2026). Tremor Control and Patient Reported Outcomes after Bilateral Focused Ultrasound Thalamotomy for Essential Tremor. Movement Disorders Clinical Practice, 13(7), 1653-1661. https://doi.org/10.1002/mdc3.70412
Vancouver
Pertsch NJ, Sakakura K, Mueller JM, Kim D, Ahn YJ, Chiu LT, et al. Tremor Control and Patient Reported Outcomes after Bilateral Focused Ultrasound Thalamotomy for Essential Tremor. Movement Disorders Clinical Practice. 2026;13(7):1653-1661. doi:10.1002/mdc3.70412
BibTeX
@article{Pertsch2026,
author = {Pertsch, Nathan J and Sakakura, Kazuki and Mueller, Julia M and Kim, Dustin and Ahn, Yoo Jin and Chiu, Lucinda T and Varela, Jesus Roberto and Gattu, Havish and Patel, Shama and Pearce, John J and Swan, Christina B and Patel, Neepa and Sani, Sepehr},
title = {Tremor Control and Patient Reported Outcomes after Bilateral Focused Ultrasound Thalamotomy for Essential Tremor},
journal = {Movement Disorders Clinical Practice},
year = {2026},
volume = {13},
number = {7},
pages = {1653--1661},
doi = {10.1002/mdc3.70412}
}
EUVIMED